Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood–brain barrier cells and the modulation of key inflammatory receptors on microglia

References

• Albertazzi L, Gherardini L, Brondi M, Sulis Sato S, Bifone A, Pizzorusso T, et al. In vivo distribution and toxicity of PAMAM dendrimers in the Central Nervous System depend on their surface chemistry. Mol Pharm 2013;10(1):249–260.
   PubMed Web of Science ®Google Scholar
• Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC. 1998. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. J Immunol 161:2552–2560.
   PubMed Web of Science ®Google Scholar
• Babcock AA, Kuziel WA, Rivest S, Owens T. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23:7922–7930.
   PubMed Web of Science ®Google Scholar
• Bardi G, Malvindi MA, Gherardini L, Costa M, Pompa PP, Cingolani R, et al. 2010. The biocompatibility of amino functionalized CdSe/ZnS quantum-dot-Doped SiO2 nanoparticles with primary neural cells and their gene carrying performance. Biomaterials 31:6555–6566.
   PubMed Web of Science ®Google Scholar
• Brown RC, Morris AP, O'Neil RG. 2007. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 1130:17–30.
   PubMed Web of Science ®Google Scholar
• Chen Y, Dalwadi G, Benson HA. 2004. Drug delivery across the blood-brain barrier. Curr Drug Deliv 1:361–376.
   PubMedGoogle Scholar
• Cohen S. 1976. Cell mediated immunity and the inflammatory system. Hum Pathol 7:249–264.
   PubMed Web of Science ®Google Scholar
• Daniel WA. 2003. Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 27:65–73.
   PubMed Web of Science ®Google Scholar
• Dhanikula RS, Hammady T, Hildgen P. 2009. On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood-brain barrier model. J Pharm Sci 98:3748–3760.
   PubMed Web of Science ®Google Scholar
• Duncan R, Izzo L. 2005. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215–2237.
   PubMed Web of Science ®Google Scholar
• Gagliardi M, Bardi G, Bifone A. 2012. Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS. Ther Deliv 3:875–887.
   PubMedGoogle Scholar
• Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi X, et al. 2004. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 15:774–782.
   PubMed Web of Science ®Google Scholar
• Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, et al. 2006. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem 17:728–734.
   PubMed Web of Science ®Google Scholar
• Huang D, Wujek J, Kidd G, He TT, Cardona A, Sasse ME, et al. 2005. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J 19:761–772.
   PubMed Web of Science ®Google Scholar
• Kannan S, Dai H, Navath RS, Balakrishnan B, Jyoti A, Janisse J, et al. 2012. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med 4:130ra46.
   PubMed Web of Science ®Google Scholar
• Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson K. A. 2010. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31:9511–9518.
   PubMed Web of Science ®Google Scholar
• Li G, Simon MJ, Cancel LM, Shi ZD, Ji X, Tarabell JM, et al. 2010. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies. Ann Biomed Eng 38:2499–2511.
   PubMed Web of Science ®Google Scholar
• Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, Cingolani R, et al. 2010. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 4:7481–7491.
   PubMed Web of Science ®Google Scholar
• Martin H, Kinns H, Mitchell N, Astier Y, Madthil R, Howorka S. 2007. Nanoscale protein pores modified with PAMAM dendrimers. J Am Chem Soc 129:9640–9649.
   PubMed Web of Science ®Google Scholar
• Meng F, Lowell CA. 1997. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J Exp Med 185:1661–1670.
   PubMed Web of Science ®Google Scholar
• Mukherjee SP, Byrne HJ. 2012. Polyamidoamine dendrimer nanoparticle cytotoxicity, oxidative stress, caspase activation and inflammatory response: experimental observation and numerical simulation. Nanomedicine 2012 May 23. [Epub ahead of print]
   Web of Science ®Google Scholar
• Mukherjee SP, Davoren M, Byrne HJ. 2010a. In vitro mammalian cytotoxicological study of PAMAM dendrimers - towards quantitative structure activity relationships. Toxicol In Vitro 24:169–177.
   PubMed Web of Science ®Google Scholar
• Mukherjee SP, Lyng FM, Garcia A, Davoren M, Byrne HJ. 2010b. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol Appl Pharmacol 248:259–268.
   PubMed Web of Science ®Google Scholar
• Naka K. 2003. Effect of dendrimers on the crystallization of calcium carbonate in aqueous solution. Top Curr Chem 228:141–158.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. 2007. Blood-brain barrier delivery. Drug Discov Today 12:54–61.
   PubMed Web of Science ®Google Scholar
• Pavan GM, Monteagudo S, Guerra J, Carrion B, Ocana V, Rodriguez-Lopez J, et al. 2012. Role of generation, architecture, pH and ionic strength on successful siRNA delivery and transfection by hybrid PPV-PAMAM dendrimers. Curr Med Chem 19(29):4929–4941.
   PubMed Web of Science ®Google Scholar
• Perez-Martinez FC, Guerra J, Posadas I, Cena V. 2011. Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharm Res 28:1843–1858.
   PubMed Web of Science ®Google Scholar
• Perez-Martinez FC, Ocana AV, Perez-Carrion MD, Cena V. 2012. Dendrimers as vectors for genetic material delivery to the nervous system. Curr Med Chem 19(29):5101–5108.
   PubMed Web of Science ®Google Scholar
• Posadas I, Guerra FJ, Cena V. 2010. Nonviral vectors for the delivery of small interfering RNAs to the CNS. Nanomedicine (Lond) 5:1219–1236.
   PubMed Web of Science ®Google Scholar
• Poupot M, Griffe L, Marchand P, Maraval A, Rolland O, Martinet L, et al. 2006. Design of phosphorylated dendritic architectures to promote human monocyte activation. FASEB J 20:2339–2351.
   PubMed Web of Science ®Google Scholar
• Prinz M, Priller J, Sisodia SS, Ransohoff RM. 2011. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 14:1227–1235.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM, Liu L, Cardona AE. 2007. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol 82:187–204.
   PubMed Web of Science ®Google Scholar
• Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762–774.
   PubMed Web of Science ®Google Scholar
• Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. 2008. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv 5:155–174.
   PubMed Web of Science ®Google Scholar